case report aspiration semaglutide anesthesia 2023 Doctors warn some popular weight-loss drugs may raise risk of complications under GLP-1 agonists: a new hope
Description
The abdomen, thigh, and upper arm are the most common sites, each with advantages and considerations
Some reports indicate that higher dosages are related to more significant side effects and potential injuries
Nat Metab 5(2):186192
Neither holds MHRA marketing authorisation in the UK
But it is not a quick fix, and it is not FDA-approved by itself for weight loss
10.1080/21655979.2021.2012627 119 ZhouC.ChenX.ZengW.PengC.HuangG.LiX.et al (2016)
